Back to Pt-141 research
pt-141 melanocortin agonist other 2026-04-11 EuropePMC

OB-GYNs' Attitudes and Practices Regarding Maternal Vaccination: A National Survey

Provider Attitudes and Practices Regarding Maternal Vaccination Among Obstetrician-Gynecologists: A National Survey

Background

Maternal vaccination is a crucial public health strategy to protect both pregnant individuals and their newborns from preventable infectious diseases like influenza and pertussis (whooping cough). Despite clear recommendations from health organizations, vaccination rates among pregnant populations often remain suboptimal. This study addresses the specific knowledge gap regarding the current attitudes, practices, and perceived barriers among obstetrician-gynecologists (OB-GYNs) in recommending and administering these vital vaccines.

Results

The survey revealed high rates of recommendation for key maternal vaccines, with 92% of OB-GYNs reporting they routinely recommend the influenza vaccine and 85% recommending the Tdap vaccine to their pregnant patients. However, actual administration rates within their practices were lower, with only 45% administering influenza vaccines and 30% administering Tdap vaccines directly. The most significant barrier identified by 68% of respondents was "patient refusal/hesitancy," followed by "lack of time during visits" (55%) and "logistical issues with vaccine storage/supply" (40%). Providers who reported receiving specific training on maternal vaccination were 1.8-fold more likely to administer vaccines in their practice compared to those without such training (p<0.01). Furthermore, 75% of OB-GYNs felt confident discussing vaccine safety with patients, but 60% desired more educational resources.

Why It Matters

This study underscores the critical role of OB-GYNs as trusted sources of information for pregnant patients regarding vaccination. While recommendation rates are high, the discrepancy between recommendation and direct administration highlights significant systemic and patient-related barriers that need to be addressed. Understanding these challenges is crucial for developing targeted interventions and educational programs to improve maternal vaccination uptake and ultimately enhance public health outcomes for mothers and infants. Future efforts should focus on providing practical support for in-office vaccine administration and enhancing communication strategies to address patient hesitancy.


pt-141 melanocortin agonist
Source: europepmc:epmc_PMC5630996 · Ingested 2026-04-11 · Digest: gemini-2.5-flash